Literature DB >> 17964030

Brain metastases.

Teri D Nguyen1, Lisa M DeAngelis.   

Abstract

Brain metastases are a common complication of cancer and alter patient management more than metastases at any other site of distant progression. Supportive therapies include steroids and antiseizure medications. Definitive treatments include radiation therapy, surgery, and chemotherapy. The optimal choice of treatment and overall prognosis largely depend on patient characteristics and the extent and distribution of disease. Delaying or decreasing neurologic cause of death and disability are important therapeutic goals for this population. While better definitive strategies are investigated, physicians must remember to optimize the use of supportive therapies to ameliorate symptoms and maintain quality of life.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964030     DOI: 10.1016/j.ncl.2007.07.011

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  9 in total

1.  Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma.

Authors:  Alberto Broniscer; Justin N Baker; Suzanne J Baker; Susan N Chi; J Russell Geyer; E Brannon Morris; Amar Gajjar
Journal:  Cancer       Date:  2010-10-01       Impact factor: 6.860

2.  Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.

Authors:  Andrés Server; Tone E Døli Orheim; Bjørn A Graff; Roger Josefsen; Theresa Kumar; Per H Nakstad
Journal:  Neuroradiology       Date:  2010-07-13       Impact factor: 2.804

3.  Predicting brain metastases for non-small cell lung cancer based on magnetic resonance imaging.

Authors:  Gang Yin; Churong Li; Heng Chen; Yangkun Luo; Lucia Clara Orlandini; Pei Wang; Jinyi Lang
Journal:  Clin Exp Metastasis       Date:  2017-01-18       Impact factor: 5.150

4.  Non-viral gene delivery nanoparticles based on poly(β-amino esters) for treatment of glioblastoma.

Authors:  Stephany Y Tzeng; Hugo Guerrero-Cázares; Elliott E Martinez; Joel C Sunshine; Alfredo Quiñones-Hinojosa; Jordan J Green
Journal:  Biomaterials       Date:  2011-05-04       Impact factor: 12.479

Review 5.  Breast Cancer Brain Metastasis: The Potential Role of MRI Beyond Current Clinical Applications.

Authors:  Andria Hadjipanteli; Paul Doolan; Efthyvoulos Kyriacou; Anastasia Constantinidou
Journal:  Cancer Manag Res       Date:  2020-10-12       Impact factor: 3.989

6.  Palliative external beam radiotherapy for advanced breast cancer patients with brain metastasis in the university college hospital Ibadan.

Authors:  Hassan Ibrahim; Aliyu Ango Yaroko
Journal:  Ann Afr Med       Date:  2019 Jul-Sep

Review 7.  Treatment of Brain Metastases of Non-Small Cell Lung Carcinoma.

Authors:  Agnieszka Rybarczyk-Kasiuchnicz; Rodryg Ramlau; Katarzyna Stencel
Journal:  Int J Mol Sci       Date:  2021-01-08       Impact factor: 5.923

8.  TGFβ1 Polymorphisms Predict Distant Metastasis-Free Survival in Patients with Inoperable Non-Small-Cell Lung Cancer after Definitive Radiotherapy.

Authors:  Xianglin Yuan; Qingyi Wei; Ritsuko Komaki; Zhensheng Liu; Ju Yang; Susan L Tucker; Ting Xu; John V Heymach; Charles Lu; James D Cox; Zhongxing Liao
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240

9.  Palliative whole-brain radiotherapy and health- related quality of life for patients with brain metastasis in cancer.

Authors:  Ying Gao; Fei Gao; Jin-Lu Ma; Dong-Li Zhao
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-21       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.